According to the Zhitong Finance App, Dongrui Pharmaceutical (02348) announced that on October 20, 2026, the company will spend HK$284,000 to repurchase 300,000 shares at a repurchase price of HK$0.945-0.95 per share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.